It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2020.
2020 | Ahmedabad, Gujarat, India | ActiveNeupron Pharmaceuticals Private Limited, a active private limited company, was established on 26 June 2020 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299GJ2020PTC114153. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Rekha Sharma (Director), Ravikumar Ghanshyam Swami (Director), Ridhima Sharma (Additional Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at I-10, Ratnam Flats, B/H- Kundan Tenament Part-2, Vasna, Ahmedabad, Gujarat, 380007.
U24299GJ2020PTC114153
114153
26 June 2020
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Neupron Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekha Sharma | Director | 26 Jun 2020 | Current |
| Ravikumar Ghanshyam Swami | Director | 26 Jun 2020 | Current |
| Ridhima Sharma | Additional Director | 17 Jun 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neupron Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.65% increase. The company also saw a substantial fall in profitability, with a 364.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 335.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Neupron Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Neupron Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neupron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neupron Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ridhima Sharma was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2025 & has been associated with this company since 6 months 4 days . was recorded as a recent event.
Progress on Neupron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Neupron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Rekha Sharma was appointed as a Director was appointed as a Director on 26 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on Ravikumar Ghanshyam Swami was appointed as a Director was appointed as a Director on 26 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
Progress on Neupron Pharmaceuticals Private Limited was registered on 26 Jun 2020 with Roc Ahmedabad & aged 5 years 5 months as per MCA records. was documented.
The CIN of Neupron Pharmaceuticals Private Limited is U24299GJ2020PTC114153.
Neupron Pharmaceuticals Private Limited is headquartered at I-10, Ratnam Flats, B/H- Kundan Tenament Part-2, Vasna, Ahmedabad, Gujarat, 380007.
Neupron Pharmaceuticals Private Limited was incorporated on 26 June 2020.
The current directors of Neupron Pharmaceuticals Private Limited are
The primary industry of Neupron Pharmaceuticals Private Limited is Trade.
Neupron Pharmaceuticals Private Limited is unlisted.
The authorized capital of Neupron Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX